Free tool
Oncology stocks
We cover 6 companies grouped under the Oncology theme. The median market value in the group is $244.95M. Across the group, the median move over the past trading day is 0.00%. Price change over the past year runs from −17.8% to +2976.8% across the middle 80 percent of the group, with a median of −0.5%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
6 of 319 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return | Next report |
|---|---|---|---|---|---|
| PRTC.L | PureTech Health plc | $402.61M | Small cap | −11.34% | Aug 27, 2026 |
| IDD.DE | Innate Pharma S.A. | $247.30M | Small cap | −2.52% | Sep 17, 2026 |
| IPH.PA | Innate Pharma S.A. | $244.95M | Small cap | +1.84% | Sep 17, 2026 |
| BINV.ST | BioInvent International AB (publ) | $169.15M | Small cap | −24.30% | Aug 27, 2026 |
| 0RU5.L | Oncoinvent ASA | $128.23M | Small cap | +5951.72% | Aug 27, 2026 |
| 0VQ.DE | PureTech Health plc | — | — | +1.50% | Aug 27, 2026 |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.